Tianjin Chase Sun Pharmaceutical Co Ltd (300026) — Tangible Net Worth Ratio

Latest as of March 2026: 93.1%

Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has a Tangible Net Worth Ratio of 93.1% as of March 2026. This metric is calculated by deducting intangible assets (CN¥605.69 Million) from net assets (CN¥8.72 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Tianjin Chase Sun Pharmaceutical Co Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Tangible NW Ratio

93.1%
Tangible equity / total equity

Net Assets (Equity)

CN¥8.72 Billion
CNY

Intangible Assets

CN¥605.69 Million
Goodwill, patents, brand value

Total Assets

CN¥10.37 Billion
CNY

Tianjin Chase Sun Pharmaceutical Co Ltd Tangible Net Worth Ratio (2006–2024)

This chart shows how Tianjin Chase Sun Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 19 annual periods from 2006 to 2024. As of March 2026, the ratio stands at 93.1%, reflecting net assets of CN¥8.72 Billion with intangible assets of CN¥605.69 Million CNY. See Tianjin Chase Sun Pharmaceutical Co Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Annual Tangible Net Worth Ratio for Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2024)

The table below presents the year-by-year Tangible Net Worth Ratio for Tianjin Chase Sun Pharmaceutical Co Ltd from 2006 to 2024, covering 19 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Tianjin Chase Sun Pharmaceutical Co Ltd (300026) total market value.

Year Tangible NW Ratio Net Assets (CNY) Intangible Assets Total Assets Change (pp)
2024 92.8% CN¥8.80 Billion CN¥634.49 Million CN¥11.17 Billion ▲ +0.4 pp
2023 92.4% CN¥8.87 Billion CN¥672.54 Million CN¥11.84 Billion ▼ -0.3 pp
2022 92.7% CN¥8.46 Billion CN¥613.93 Million CN¥12.63 Billion ▼ -0.3 pp
2021 93.0% CN¥7.95 Billion CN¥554.38 Million CN¥11.61 Billion ▼ -0.3 pp
2020 93.3% CN¥7.39 Billion CN¥495.79 Million CN¥10.18 Billion ▲ +0.0 pp
2019 93.3% CN¥7.07 Billion CN¥476.34 Million CN¥8.43 Billion ▼ -0.4 pp
2018 93.7% CN¥6.58 Billion CN¥414.36 Million CN¥7.48 Billion ▼ -0.5 pp
2017 94.2% CN¥6.51 Billion CN¥376.49 Million CN¥7.43 Billion ▼ -0.6 pp
2016 94.8% CN¥6.04 Billion CN¥311.40 Million CN¥7.28 Billion ▼ -0.1 pp
2015 94.9% CN¥5.29 Billion CN¥269.65 Million CN¥6.47 Billion ▲ +2.1 pp
2014 92.8% CN¥2.36 Billion CN¥170.70 Million CN¥3.04 Billion ▼ -1.5 pp
2013 94.2% CN¥1.70 Billion CN¥98.42 Million CN¥2.22 Billion ▲ +0.6 pp
2012 93.6% CN¥1.39 Billion CN¥88.41 Million CN¥1.80 Billion ▲ +1.7 pp
2011 92.0% CN¥1.05 Billion CN¥84.36 Million CN¥1.41 Billion ▼ -1.9 pp
2010 93.9% CN¥1.10 Billion CN¥66.85 Million CN¥1.28 Billion ▼ -1.4 pp
2009 95.3% CN¥926.88 Million CN¥43.20 Million CN¥1.06 Billion ▲ +16.9 pp
2008 78.4% CN¥125.51 Million CN¥27.10 Million CN¥217.14 Million ▲ +12.2 pp
2007 66.2% CN¥61.24 Million CN¥20.70 Million CN¥175.03 Million ▲ +45.6 pp
2006 20.6% CN¥21.28 Million CN¥16.89 Million CN¥105.62 Million
pp = percentage points